About
In this journal club, we will examine published data on the effects of different legal market forms of cannabis on anxiety symptoms from a study published from the Journal of Cannabis and Cannabinoid Research (Link to article below). The event is hosted by Phil Molloy, MD, Len Kamen, MD, Teresa Simon, MPH, and Jahan Marcu, PhD.
Who Should Attend:
This event is intended for doctors and healthcare professionals keen on staying abreast of the latest developments related to the cardiovascular system and cannabinoid research. This discussion will also be relevant for researchers, public health specialists, regulators, and students interested in substance use and the cardiovascular system. It offers a platform for a multidisciplinary dialogue on an issue of growing importance in our communities.
Special Features:
- Expert-led Presentation on Recent Scientific Publications
- Interactive Q&A and Discussion Sessions
- Updates on Current Research Projects and Data Collection Programs
- Content and Resources for the Discussion (check back for updates)
Acute and Extended Anxiolytic Effects of Cannabidiol in Cannabis Flower: A Quasi-Experimental ad libitum Use Study
Objectives:
- To help participants to be able to explain how THC-dominant and CBD-dominant cannabis may impact anxiety symptoms differently.
- To discuss the strengths and limitations of the authors methodological approach in studying the effects of cannabis on anxiety.
